References
- Arnold D. L., Moodie C. A., Grice H. C., Charbonneau S. M., Stavric B., Collins B. T., McGuire P. F., Zawidzka Z. Z., Munro I. C. Toxic, appl. Pharmac 1980; 52: 113
- Ball L. M., Renwick A. G., Williams R. T. Xenobiotica 1977; 7: 189
- Byard J. L., McChesney E. W., Golberg L., Coulston F. Fd. Cosmet. Tox 1974; 52: 175
- Colburn W. A., Bekersky I., Blumenthal H. P. J. clin. Pharmac 1981; 21: 147
- Gibaldi M., Perrier D. Pharmacokinetics. Marcel Dekker, New York 1975
- Hoover R., Strasser P. H. Lancet 1980; II: 837
- Lethco E. J., Wallace W. C. Toxicology 1975; 3: 287
- Morrison A. S., Buring J. E. New Engl. J. Med. 1980; 302: 537
- NAS. Saccharin: Technical Assessment of Risks and Benefits, Report No. 1. Institute of Medicine, National Research Council-National Academy of Sciences, Washington, DC 1978
- Sweatman T. W., Renwick A. G. Science 1979; 205: 1019
- Sweatman T. W., Renwick A. G. Toxic, appl. Pharmac 1980; 55: 18
- Taylor J. M., Weinberger M. A., Friedman L. Toxic, appl. Pharmac 1980; 54: 57
- Wynder E. L., Stellman S. D. Science 1980; 207: 1214